IPO Year: 2022
Exchange: NASDAQ
Date | Price Target | Rating | Analyst |
---|
MIAMI, April 16, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 80th Emerging Growth Conference on April 16 & 17, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Day 1 - TodayApril 16, 2025 9:00Virtual Lobby opens.Register for the Conference. If you already registered, go back to t
MIAMI, April 15, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 81th Emerging Growth Conference on April 16 & 17, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Day 1April 16, 2025 9:00Virtual Lobby opens.Register for the Conference. If you already register
SCHEDULE 13G/A - Aspire Biopharma Holdings, Inc. (0001847345) (Subject)
EFFECT - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)
8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)
SCHEDULE 13G/A - Aspire Biopharma Holdings, Inc. (0001847345) (Subject)
SCHEDULE 13G/A - Aspire Biopharma Holdings, Inc. (0001847345) (Subject)
S-1 - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)
10-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)
SCHEDULE 13G/A - Aspire Biopharma Holdings, Inc. (0001847345) (Subject)
NT 10-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)
SCHEDULE 13G/A - Aspire Biopharma Holdings, Inc. (0001847345) (Subject)